Research Excellence
-
Exciting study to investigate new treatment for acute myeloid leukaemia
Posted on:
The Cancer Council NSW today announced funding for a new stem cell team at the Kolling Institute to examine a revolutionary approach to treatment for those with acute myeloid leukaemia. This aggressive form of blood cancer has a tragically poor survival rate, and while we have seen tremendous progress for many other types of cancer
Category:
-
New cutting-edge technology coming to the Kolling
Posted on:
The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities. The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University
Category:
-
Program supporting injured workers wins top award
Posted on:
Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury. Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers. The program
Category:
-
Researchers confirm extreme heat increases the risk of premature births
Posted on:
Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk. Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born
Category:
-
Study confirms deadly risk of COVID-19 for those with heart failure
Posted on:
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19. Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed
-
Research identifies swallowing problems following whiplash
Posted on:
Research conducted by a team from Kolling Institute has found that swallowing difficulties after a whiplash injury appear to be an under-recognised consequence of the injury. The study investigated a group of 60 patients with low-grade whiplash, finding 50 per cent of patients reported swallowing problems within 12 months of their whiplash injury. In 31
Category:
-
Researchers reject the use of plasma injections for knee joint osteoarthritis
Posted on:
In what will be disappointing news for many, a large-scale clinical trial has found platelet-rich plasma injections for those with osteoarthritis knee pain are no better than a placebo. This type of injection has become an increasingly popular form of treatment for knee joint arthritis, despite its prohibitive cost at around $2,000 per injection. Plasma
Category:
-
Blueprint to strengthen research and improve the care we receive
Posted on:
The Kolling’s new research plan has been confirmed marking an important milestone for the institute. The plan details the implementation of the institute’s five-year strategy, and will ensure the Kolling is in the best position to deliver game-changing research. Acting Executive Director Professor Jim Elliott has welcomed the development of the plan, saying a robust
Category:
-
High-profile appointment
Posted on:
The Kolling Institute’s Executive Director Professor Carolyn Sue will join a dynamic group of Australian leaders on the new National Health and Medical Research Council. Professor Sue has been appointed to the high profile body for a three-year term until June 2024. A record number of women are represented on the new council, including chair
Category:
-
Researchers develop new program to reduce medication burden
Posted on:
A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines. Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain. Cumulatively however, they can cause serious adverse effects such
Category:
Copyright © 2026 Kolling Institute
All rights reserved